Effects of tripterine on mRNA expression of TGF-β1 and collagen IV expression in BW F1 mice

Cell Biochemistry and Function

Volumn 25, Issue 5, 2007, Pages 501-507

  Xu, Xunhui ^a   Zhong, Jian ^a   Wu, Zhaolong ^a   Fang, Yi ^a   Xu, Chen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

BWF1 mice; Collagen type IV; Immunosuppressant; TGF 1 mRNA; Tripterine

Indexed keywords

COLLAGEN TYPE 4; DOUBLE STRANDED DNA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TRIPTERINE; TRIPTERYGIUM WILFORDII EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; COLLAGEN TYPE IV; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; KIDNEY; MICE; POLYMERASE CHAIN REACTION; PROTEINURIA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1; TRITERPENES;

MURINAE; MUS;

EID: 34548802375     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1338     Document Type: Article

References (26)

1. He W, Huang FC, Gava A, et al. Novel cytokine release inhibitors. Part III: Truncated analogs of tripterine. Bioorg Med Chem Lett 1998; 8: 3659-3664.
2. Allian AC, Cacabelos R, Lombardi VR, Alvarez XA, Vigo C. Celastrol, a potent antioxidant and anti-inflammatory drug. As a possible treatment for Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 1341-1357.
3. Zhang DH, Huang XQ, Yang CH, et al. Induction of apoptosis in human T leukemiac cell line CEM-6T by tripterine: Comparison with arsenic oxide and hydroxyl camptothecin. Cell Res 2002; 12: 273.
4. Zhang LX, Yu FK, Zhang QY, Fang Z, Pan DJ. Immunosuppressive and anti-inflammatory activities of tripterine. Acta Pharmaceutica Sinica 1990; 25: 573-577.
5. Li H, Zhang YY, Huang XY, Sun YN, Jia YF, Li D. Beneficial effect of tripterine on systemic lupus erythematosus induced by active chromatin in BALB/c mice. Eur J Pharmacol 2005; 512: 231-237.
6. Vyse TJ, Drake CG, Rozzo SJ, et al. Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. J Clin Inves 1996; 98: 1762-1772.
7. Winkler TH, Jahn S, Lalden JR. IgG human monoclonal antiDNA autoantibodies from patients with systemic lupus erythematosus. Clin Exp Immunol 1991; 85: 379-385.
8. Cheng J, Grande JP. Transforming growth factor-β signal transduction and progressive renal disease. Exp Biol Med 2002; 227: 943-956.
9. Boider WA, Ruoslahti E. Transforming growth factor β in disease: The dark side of tissue repair. J Clin Invest 1992, 90: 1-7.
10. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
11. Isono M, Iglesias-de La Cruz M, Chen S, Hong SW. Extracellular signal-regulated kinase mediates stimulation of Transforming growth factor β1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 2000; 11: 2222-2230.
12. Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW. TGF-β1 activates MAP kinase in human mesangial cells: A possible role in collagen expression. Kidney Int 1999; 56: 1710-1720.
13. Grande JP, Melder DC, Zinsmeister AR. Modulation of collagen gene expression by cytokines: Stimulatory effect of transforming growth factor-β1, with divergent effects of epidermal growth factor and tumor necrosis factor-α on collagen type 1 and collagen type IV J Lab Clin Med 1997; 130: 476-486.
14. Chai Q, Krag S, Miner JH, Nyengaard JR, Chai S, Woensen L. TGF-β1 induces aberrant laminin chain and collagen type IV isotype expression in the glomerular basement membrance. Nephron 2003; 94: 123-136.
15. Emlen W, Jarusiripipat P, Burdick G. A new ELISA for the detection of double-stranded DNA antibodies. J Immunol Methods 1990; 132: 91-102.
16. Read SM, Northoote DH. Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding protein. Anal Biochem 1981; 116: 55-64.
17. Derynck R, Jarrett JA, Chen EY, Goeddel DV The murine transforming growth factor-beta precursor. J Biol Chem 1986; 261: 4377-4379.
18. Corna D, Morigi M, Faschinetti D, et al. Mocophenolate mofetil limits renal limits renal damage and prolongs life in marine lupus autoimmune disease. Kidney Int 1997; 51: 1583-1589.
19. Xu X, Wu Z, Xu C, Ren Y, Ge Y. Observation on serum anti-double stranded DNA antibodies of tripterine in systemic lupus erythematosus of (NZB X W) F1 mice (letter). Ann Rheum Dis 2003; 62: 377-378.
20. Kitamura M, Suto T. TGF-β1 and glomerulonephritis: Antiinflammatory versus prosclerotic actions. Nephrol Dial Transpl 1997; 12: 669-679.
21. Goumenos DS, Tsamandas AC, Oldroyd S, et al. Transforming Growth Factor-β1 and myofibroblasts: A potential pathway towards renal scarring in human glomerular disease. Nephron 2001; 87: 240-248.
22. Wu Z, Zhou Q, Lan Y, Wang Y, Xu X, Jin H. AP-1 complexes mediate oxidized LDL-induced overproduction of TGF β1 in rat mesangial cells. Cell Biochem Funct 2004; 22: 237-247.
23. Lam S, van der Geest RN, Verhagen NAM, Daha MR, van Kooten C. Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF β1-independent pathway. Nephrol Dial Transplant 2004; 19: 1694-1701.
24. Pithon-curi TC, Sellitti DF, Curi R, Machado MM, Hirszel P, Doi SQ. Requirement for glutamine in the expression of alpha-actin and type IV collagen in mesangial cells. Cell Biochem Funct 2006; 24: 217-221.
25. Grande JP, Warner IM, Walker HJ, et al. TGFβ1 is an autocrine mediator of renal tubular epithelial cell growth and collagen IV production. Exp Biol Med 2002; 227: 171-181.
26. Vleming LG, Baelde JJ, Westendorp RG, Daha MR, van Es LA, Bruijn JA. Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clin Nephrol 1995; 42: 211-219.